Company / Operating Income per Share
LEXICON PHARMACEUTICALS, INC. Operating Income per Share History
FY2013-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$0.47
FY2025
5-year range
-$1.22 / -$0.45
FY2021-FY2025
Trend
+22.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Income per Share returned to growth in FY2025 after 2 years of decline, reaching $-0.47.
Based on SEC 10-K filings.
-0.47 in FY2025.
Improved from $-0.60 to $-0.47 over the past 2 years.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating income per share increased 22.2% year-over-year.
- Peak operating income per share was recorded in FY2017.
- Lowest operating income per share in the period was in FY2015.
Company context
Key Data Points
- Altman Z-Score -1.98 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$0.47 | +22.2% |
| FY2024 | -$0.61 | -1.7% |
| FY2023 | -$0.60 | -32.2% |
| FY2019 | -$0.45 | +63.1% |
| FY2018 | -$1.22 | -8740.2% |
| FY2017 | $0.01 | +101.1% |
| FY2016 | -$1.31 | +5.9% |
| FY2015 | -$1.40 | -530.8% |
| FY2014 | -$0.22 | +33.9% |
| FY2013 | -$0.33 | -5.9% |
As of FY2025 · SEC 10-K Annual Filings · Updated Jun 24, 2026